KNSAKINIKSA PHARMACEUTICALS INTE
CUSIP G52694109 · common stock
4 tracked investors held KINIKSA PHARMACEUTICALS INTE (KNSA) at the end of Q3 2026, worth $236.7M in total. The largest holder was Julian Baker, with 1.0% of its portfolio.
Holders · Q3 2026
4
New holders
0
Value held
$236.7M
Quarter-end price (est.)
$74.61
Investors holding KNSA · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Julian Baker Baker Bros. Advisors LP | 1.00% | 2,834,643 | $211.5M | HOLD |
| Ken Fisher Fisher Asset Management, LLC | 0.01% | 323,808 | $24.2M | REDUCE-18.7% |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.03% | 9,258 | $690.7K | REDUCE-65.6% |
| Joel Greenblatt Gotham Asset Management, LLC | 0.00% | 4,219 | $314.8K | REDUCE-12.1% |